Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Overview of Anticoagulant Drugs Pharmacology, Therapeutic Approaches, Limitations and Perspectives. | Pharmaceutics | 2026 | 41754906 | PubTator, text mining | PubMed |
| Contemporary Challenges in Venous Thromboembolism: Evolving Populations and Implications for Management and Risk Stratification. | J Clin Med | 2026 | 41753198 | PubTator, text mining | PubMed |
| [Factor XI inhibition in atrial fibrillation: where do we stand?] | G Ital Cardiol (Rome) | 2026 | 41738422 | PubTator, text mining | PubMed |
| Quantifying Lupus Anticoagulant Interference in Intrinsic Coagulation Factor Activity Assays and Evaluating the Corrective Performance of the SCT-Based Method. | Clin Appl Thromb Hemost | 2026 | 41733920 | PubTator, text mining | PubMed |
| Dealing with heavy menstrual bleeding in very rare bleeding disorders: from a patient's perspective. | Res Pract Thromb Haemost | 2026 | 41732302 | PubTator, text mining | PubMed |
| Proteomics profiling of serum and liver in GSD Ia and Ib patients: insights into complication mechanisms and circulation biomarkers. | J Transl Med | 2026 | 41721410 | PubTator, text mining | PubMed |
| Direct Oral Anti-Xa Anticoagulants and the Future of Factor XI/FXIa Inhibition: A New Paradigm in Thrombosis Prevention. | Pharmacy (Basel) | 2026 | 41718220 | PubTator, text mining | PubMed |
| Proteomic Insights into Venous Thromboembolism. | Med Sci (Basel) | 2026 | 41718141 | PubTator, text mining | PubMed |
| CD163 and the FVIII/FXII ratio identified as novel biomarkers for early sepsis recognition. | Front Med (Lausanne) | 2026 | 41716794 | PubTator, text mining | PubMed |
| Case Report: Upper extremity deep vein thrombosis revealing an occult invasive ductal breast carcinoma. | Front Cardiovasc Med | 2026 | 41710359 | PubTator, text mining | PubMed |
| Factor VIII in vitro bioequivalence of denecimig (Mim8) hemostatic effect by thrombin generation assays. | Res Pract Thromb Haemost | 2026 | 41704799 | PubTator, text mining | PubMed |
| Antithrombotic therapy for cancer-associated venous thromboembolism. | Clin Res Cardiol | 2026 | 41701347 | PubTator, text mining | PubMed |
| Coagulation factor XI and cardiovascular disease: A complex, cardio-specific conundrum. | Med | 2026 | 41690296 | PubTator, text mining | PubMed |
| Challenges in Balancing Hemostasis and Thrombosis in Therapy Tailoring for Hemophilia: A Narrative Review. | Int J Mol Sci | 2026 | 41683793 | PubTator, text mining | PubMed |
| Safety, tolerability, pharmacokinetics, and pharmacodynamics of KN060, a humanized anti-FXI/FXIa dual-domain antibody, following single ascending doses in healthy Chinese subjects. | Res Pract Thromb Haemost | 2026 | 41676355 | PubTator, text mining | PubMed |
| Antithrombotic therapy in patients with atrial fibrillation: unresolved issues and future directions. | J Thromb Haemost | 2026 | 41638577 | PubTator, text mining | PubMed |
| Abelacimab vs Rivaroxaban in Older Individuals With Atrial Fibrillation: A Prespecified Analysis of the Phase 2b AZALEA-TIMI 71 Trial. | JAMA Cardiol | 2026 | 41637102 | PubTator, text mining | PubMed |
| Activated partial thromboplastin time prolongation without hemorrhagic dienhesis: a study of a chinese family coexisting with hereditary KNG1 p.Arg240 mutation and --SEA/αα genotype thalassemia. | Ann Hematol | 2026 | 41634406 | PubTator, text mining | PubMed |
| Simplifying the next-generation of anticoagulants: Elexians - Why a unified nomenclature for FXI/XIa inhibitors is needed. | Thromb Res | 2026 | 41633294 | PubTator, text mining | PubMed |
| Platelets as Central Modulators of Post-Cardiac Arrest Syndrome: Mechanisms and Therapeutic Implications. | Biomolecules | 2026 | 41594674 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=4